Pharma data yield from newborn blood spots 'can be tripled'
Pharma analysis of newborn blood could improve threefold with a new method

Bioanalytical

Pharma data yield from newborn blood spots 'can be tripled'

13 Jan, 2011

Published over 15 years ago. See the latest and most current information on Bioanalytical.

The commonly used pharma technique of blotting newborns' blood on to Guthrie cards in order to analyse its genetic information could be enhanced through a new technique.

Van Andel Research Institute scientists claim to have improved the process, using tools which are commercially available to triple the effectiveness of the method.

Pharma developers working on the technique, first used in 1963 by Scotland-based American microbiologist Robert Guthrie, may be interested in the findings of the study.

The process involves pricking the heel or fingertip of a newborn child up to 48 hours after birth.

Blood is then blotted on to a Guthrie card and used as a master plate in subsequent experiments to analyse its genetic make-up.

In 2009, scientists were able to demonstrate the ability to detect 3,000 different genes in a sample using the method.

However, the team now claims to have identified 9,000 genes - and says there is the potential for conditions like cerebral palsy to be detected at birth.

Latest News

Explore Our Other Sites

Labmate Online
ETH Zurich builds handheld device that detects fat burning from a single breath
Explore more Arrow
Envirotech Online
Designed for semiconductor. Proven across industries.
Explore more Arrow
Pollution Solutions Online
Sweco wins multi-year Netherlands water infrastructure framework to strengthen flood resilience and water quality
Explore more Arrow
Petro Online
Flash point testing aligned with petrochemical compliance requirements
Explore more Arrow